About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Mmom2C57BL/6J
C57BL/6J
MGI:3802646
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
ApcMin/Apc+
Mmom2129X1/SvJ/Mmom2C57BL/6J
involves: 129X1/SvJ * C57BL/6J MGI:3803126
cx2
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
involves: C57BL/6J * FVB/NTac MGI:3803125
cx3
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
Mmom3C57BL/6J/Mmom3FVB/NTac
involves: C57BL/6J * FVB/NTac MGI:3803127
cx4
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
Mmom4C57BL/6J/Mmom4FVB/NTac
involves: C57BL/6J * FVB/NTac MGI:3803128


Genotype
MGI:3803126
cx1
Allelic
Composition
ApcMin/Apc+
Mmom2129X1/SvJ/Mmom2C57BL/6J
Genetic
Background
involves: 129X1/SvJ * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ApcMin mutation (12 available); any Apc mutation (158 available)
Mmom2129X1/SvJ mutation (0 available); any Mmom2 mutation (0 available)
Mmom2C57BL/6J mutation (0 available); any Mmom2 mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• decreased mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females
• increased tumor latency

integument
• decreased mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females
• increased tumor latency

endocrine/exocrine glands
• decreased mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females
• increased tumor latency




Genotype
MGI:3803125
cx2
Allelic
Composition
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
Genetic
Background
involves: C57BL/6J * FVB/NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ApcMin mutation (12 available); any Apc mutation (158 available)
Mmom2C57BL/6J mutation (0 available); any Mmom2 mutation (0 available)
Mmom2FVB/NTac mutation (0 available); any Mmom2 mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 24% decrease in mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females
• increased tumor latency

endocrine/exocrine glands
• 24% decrease in mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females
• increased tumor latency

integument
• 24% decrease in mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females
• increased tumor latency




Genotype
MGI:3803127
cx3
Allelic
Composition
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
Mmom3C57BL/6J/Mmom3FVB/NTac
Genetic
Background
involves: C57BL/6J * FVB/NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ApcMin mutation (12 available); any Apc mutation (158 available)
Mmom2C57BL/6J mutation (0 available); any Mmom2 mutation (0 available)
Mmom2FVB/NTac mutation (0 available); any Mmom2 mutation (0 available)
Mmom3C57BL/6J mutation (0 available); any Mmom3 mutation (0 available)
Mmom3FVB/NTac mutation (0 available); any Mmom3 mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• decreased mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females

endocrine/exocrine glands
• decreased mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females

integument
• decreased mammary tumor number after ENU treatment compared to C57BL/6J-homozygous females




Genotype
MGI:3803128
cx4
Allelic
Composition
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
Mmom4C57BL/6J/Mmom4FVB/NTac
Genetic
Background
involves: C57BL/6J * FVB/NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ApcMin mutation (12 available); any Apc mutation (158 available)
Mmom2C57BL/6J mutation (0 available); any Mmom2 mutation (0 available)
Mmom2FVB/NTac mutation (0 available); any Mmom2 mutation (0 available)
Mmom4C57BL/6J mutation (0 available); any Mmom4 mutation (0 available)
Mmom4FVB/NTac mutation (0 available); any Mmom4 mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• increased tumor latency after ENU treatment compared to C57BL/6J-homozygous females

endocrine/exocrine glands
• increased tumor latency after ENU treatment compared to C57BL/6J-homozygous females

integument
• increased tumor latency after ENU treatment compared to C57BL/6J-homozygous females





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory